Insulin independence from stem-cell-derived islets

IF 26.8 1区医学 Q1 ENGINEERING, BIOMEDICAL

Nature Biomedical Engineering Pub Date : 2024-12-23 DOI:10.1038/s41551-024-01331-2

Alessandra Griffo

引用次数: 0

Abstract

An autologous transplant of islets derived from chemically induced pluripotent stem cells allowed an individual with type 1 diabetes to forgo insulin.

查看原文本刊更多论文

干细胞来源胰岛的胰岛素独立性

从化学诱导的多能干细胞中提取的胰岛的自体移植允许1型糖尿病患者放弃胰岛素。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Nature Biomedical Engineering Medicine-Medicine (miscellaneous)

CiteScore

45.30

自引率

1.10%

发文量

138

期刊介绍： Nature Biomedical Engineering is an online-only monthly journal that was launched in January 2017. It aims to publish original research, reviews, and commentary focusing on applied biomedicine and health technology. The journal targets a diverse audience, including life scientists who are involved in developing experimental or computational systems and methods to enhance our understanding of human physiology. It also covers biomedical researchers and engineers who are engaged in designing or optimizing therapies, assays, devices, or procedures for diagnosing or treating diseases. Additionally, clinicians, who make use of research outputs to evaluate patient health or administer therapy in various clinical settings and healthcare contexts, are also part of the target audience.